Yang, Yi

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet

Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling

Cited by 942

Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury

Lu, Z., Chang, W., Meng, S., Xu, X., Xie, J., Guo, F., Yang, Y., Qiu, H., & Liu, L. (2019) · Stem Cell Research & Therapy

Mesenchymal stem cell researchImmunotherapy and Immune Responses

Cited by 146

Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis.

Peng, F., Chang, W., Xie, J.-F., Sun, Q., Qiu, H.-B., & Yang, Y. (2019) · International Journal of Infectious Diseases

Sepsis Diagnosis and TreatmentAntibiotic Use and Resistance

Cited by 49